CASP1 and Alzheimer disease: Whereas the J20 is a familial AD mouse model, the presence of the Nlrp1-Casp1-Casp6 pathway in mild cognitively impaired and in the early and late stages of sporadic human AD suggests that the treatment will also work in sporadic AD.